| Bioactivity | AP5 sodium is a potent, orall active, and selective GPR40 receptor agonist with a positive allosteric modulation of endogenous ligand (AgoPAM). AP5 sodium demonstrates rat and human inositol monophosphate (IP1) EC50 values of 0.49 nM and 0.8 nM against the GPR40 receptor, respectively. AP5 sodium has the potential for type II diabetes research[1]. |
| Name | AP5 sodium |
| CAS | 1623143-67-8 |
| Formula | C28H27FNNaO4 |
| Molar Mass | 483.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Chen HY, et al. Structure-Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMs. ACS Med Chem Lett. 2018 Jun 14;9(7):685-690. |
AP5 sodium
CAS: 1623143-67-8 F: C28H27FNNaO4 W: 483.51
AP5 sodium is a potent, orall active, and selective GPR40 receptor agonist with a positive allosteric modulation of endo
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.